Amylyx Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain. The company features a drug designed to prevent nerve cell death and degeneration. Amylyx Pharmaceuticals was founded in 2014 and headquartered in Massachusetts, United States.
Amylyx Pharmaceuticals has raised $381M across 2 funding rounds on record, the most recent a Post-IPO Equity of $246M announced in Oct 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Amylyx Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Oct 2022.
Amylyx Pharmaceuticals Funding Rounds
Amylyx Pharmaceuticals raised $135M in a Series C announced in Jul 2021.
1.3 years later, a Post-IPO Equity of $246M was announced in Oct 2022.
Amylyx Pharmaceuticals Founders and Leadership Team
Contact details for the Amylyx Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Amylyx Pharmaceuticals Funding Compared to Other Biotechnology Startups
Amylyx Pharmaceuticals' latest round of $246M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Amylyx Pharmaceuticals in Biotechnology and Cambridge
Companies Similar to Amylyx Pharmaceuticals
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Amylyx Pharmaceuticals Funding FAQs
What does Amylyx Pharmaceuticals do?
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain. The company features a drug designed to prevent nerve cell death and degeneration. Amylyx Pharmaceuticals was founded in 2014 and headquartered in Massachusetts, United States.
How much funding has Amylyx Pharmaceuticals raised?
Amylyx Pharmaceuticals has raised $381M across 2 rounds on record. The most recent is a Post-IPO Equity of $246M announced in Oct 2022.
When did Amylyx Pharmaceuticals last raise funding?
Amylyx Pharmaceuticals' most recent funding round on record is a Post-IPO Equity of $246M, announced in Oct 2022.
Who is the CEO of Amylyx Pharmaceuticals?
Joshua Cohen is listed as CEO at Amylyx Pharmaceuticals.
Where is Amylyx Pharmaceuticals headquartered?
Amylyx Pharmaceuticals is based in Cambridge, Massachusetts, United States.
How many employees does Amylyx Pharmaceuticals have?
Amylyx Pharmaceuticals is in the 51-100 employee band.
How does Amylyx Pharmaceuticals' funding compare to other Biotechnology startups?
Amylyx Pharmaceuticals' latest round of $246M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Amylyx Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Amylyx Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.